Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.610
-0.020 (-1.23%)
At close: Sep 5, 2025, 4:00 PM
1.590
-0.020 (-1.24%)
After-hours: Sep 5, 2025, 6:22 PM EDT

Aptevo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
5231238160
Upgrade
Market Cap Growth
805.28%-36.70%-71.09%-69.34%-75.96%441.40%
Upgrade
Enterprise Value
0-0-10-06163
Upgrade
Last Close Price
1.6386.205893.3775539.28256247.461193325.19
Upgrade
PE Ratio
---1.47--
Upgrade
PS Ratio
---3.783.1337.11
Upgrade
PB Ratio
0.810.450.280.6631.619.64
Upgrade
P/TBV Ratio
0.810.450.280.6631.619.64
Upgrade
EV/Sales Ratio
----0.4637.90
Upgrade
Debt / Equity Ratio
0.651.140.440.5513.751.65
Upgrade
Asset Turnover
---0.070.220.08
Upgrade
Quick Ratio
1.921.402.342.891.402.91
Upgrade
Current Ratio
2.271.722.643.151.513.25
Upgrade
Return on Equity (ROE)
-437.34%-284.28%-123.53%73.10%-330.24%-217.49%
Upgrade
Return on Assets (ROA)
-99.45%-76.06%-61.12%-39.42%-24.29%-32.13%
Upgrade
Return on Capital (ROIC)
-145.19%-110.74%-79.25%-78.06%-43.19%-43.48%
Upgrade
Earnings Yield
-453.85%-1119.01%-511.13%68.12%-74.03%-11.10%
Upgrade
FCF Yield
-465.64%-1103.01%-344.36%-178.64%-58.26%-18.39%
Upgrade
Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q